Cross-coupling reactions -- the joining of fragments of molecules with the aid of a metal catalyst -- are a critical part of pharmaceutical production, usually relying on expensive, rare metals like palladium. Researchers at the <a href="https://www.nsf.gov/cgi-bin/good-bye?https://www.rochester.edu/newscenter/big-leap-forward-in-using-iron-catalysts-for-pharmaceuticals-494352/">University of Rochester </a>and the University of Maryland, developed a three-component cross-coupling reaction that produces less expensive synthetics of hard to produce pharmaceutical compounds in one step using iron. The development simplifies an expensive and complex multi-step process to generate pharmaceutical reactions using iron as a catalyst.

Less Is The Expense, More Is The Benefit In Medicines Use.

Researchers use iron to generate new three-component cross-coupling catalytic reaction
 <img src="https://www.nsf.gov/news/mmg/media/images/iron_catalyst_f.jpg" alt="Scientists have developed a way to generate pharmaceutical reactions using iron as a catalyst." width="350" height="220">Scientists have developed a way to generate pharmaceutical reactions using iron as a catalyst. 
 December 8, 2021
 Cross-coupling reactions -- the joining of fragments of molecules with the aid of a metal catalyst -- are a critical part of pharmaceutical production, usually relying on expensive, rare metals like palladium. Researchers at the <a href="https://www.nsf.gov/cgi-bin/good-bye?https://www.rochester.edu/newscenter/big-leap-forward-in-using-iron-catalysts-for-pharmaceuticals-494352/" dir="ltr">University of Rochester</a> and the University of Maryland, partially funded by the <a href="https://www.nsf.gov/awardsearch/showAward?AWD_ID=1751568&amp;HistoricalAwards=false" dir="ltr">U.S. National Science Foundation</a>, developed a three-component cross-coupling reaction that produces less expensive synthetics of hard to produce pharmaceutical compounds in one step using iron. The findings were published in the journal <a href="https://www.nsf.gov/cgi-bin/good-bye?https://www.science.org/doi/10.1126/science.abj6005" dir="ltr">Science</a>."This is a tremendous leap forward in developing effective and practical iron-based reactions that the pharmaceutical industry could utilize," said Michael Neidig of the University of Rochester, a co-author of the study.Carbon bond-forming reactions are important in manufacturing pharmaceutical and other chemical products, but often require rare and expensive metals. Iron is inexpensive, readily available and less toxic than other metals like palladium, but the instability of the iron carbon bond has limited its use as a catalyst in this type of reaction. Replacing rare metals with abundant and non-toxic iron is more stable and sustainable.The researchers studied the mechanics of iron-catalyzed carbon bond-forming reactions and successfully created a three-component coupling that increased the potential for chemical bonds to form during the reaction and reduced the instability of the iron carbon bonding. The development simplifies an expensive and complex multi-step process to generate pharmaceutical reactions using iron as a catalyst.<div dir="ltr">--&nbsp;
 NSF&nbsp;Public Affairs,
 

 <a href="mailto:Researchnews@nsf.gov" dir="ltr"> Researchnews@nsf.gov</a>
 
 

 

 </div>

The efficacy in medical treatment obviously gets a boost when expenses are less.

NSF's mission is to advance the progress of science, a mission accomplished by funding proposals for research and education made by scientists, engineers, and educators from across the country.

personaldevelopment

Personal Development

health

Health

Researchers use iron to generate new three-component cross-coupling catalytic reaction

Scientists have developed a way to generate pharmaceutical reactions using iron as a catalyst.

December 8, 2021

Cross-coupling reactions -- the joining of fragments of molecules with the aid of a metal catalyst -- are a critical part of pharmaceutical production, usually relying on expensive, rare metals like palladium. Researchers at the <a href="https://www.nsf.gov/cgi-bin/good-bye?https://www.rochester.edu/newscenter/big-leap-forward-in-using-iron-catalysts-for-pharmaceuticals-494352/">University of Rochester </a>and the University of Maryland, partially funded by the <a href="https://www.nsf.gov/awardsearch/showAward?AWD_ID=1751568&HistoricalAwards=false">U.S. National Science Foundation </a>, developed a three-component cross-coupling reaction that produces less expensive synthetics of hard to produce pharmaceutical compounds in one step using iron. The findings were published in the journal <a href="https://www.nsf.gov/cgi-bin/good-bye?https://www.science.org/doi/10.1126/science.abj6005">Science </a> .

"This is a tremendous leap forward in developing effective and practical iron-based reactions that the pharmaceutical industry could utilize," said Michael Neidig of the University of Rochester, a co-author of the study.

Carbon bond-forming reactions are important in manufacturing pharmaceutical and other chemical products, but often require rare and expensive metals. Iron is inexpensive, readily available and less toxic than other metals like palladium, but the instability of the iron carbon bond has limited its use as a catalyst in this type of reaction. Replacing rare metals with abundant and non-toxic iron is more stable and sustainable.

The researchers studied the mechanics of iron-catalyzed carbon bond-forming reactions and successfully created a three-component coupling that increased the potential for chemical bonds to form during the reaction and reduced the instability of the iron carbon bonding. The development simplifies an expensive and complex multi-step process to generate pharmaceutical reactions using iron as a catalyst.

Low-cost iron catalyst produces less expensive pharmaceutical compounds

Less Is The Expense, More Is The Benefit In Medicines Use.

Related collections

Other curated ideas on this topic: